Four Proteins Governing Overangiogenic Endothelial Cell Phenotype in Patients With Multiple Myeloma Are Plausible Therapeutic Targets

Oncogene - United Kingdom
doi 10.1038/onc.2011.412
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

BET Bromodomain Proteins Are Therapeutic Targets in CRPC

Cancer Discovery
Oncology
2014English

The Therapeutic Potential of Cell Cycle Targeting in Multiple Myeloma

Oncotarget
Oncology
2017English

Multiple Myeloma Cell Lines and Primary Tumors Proteoma: Protein Biosynthesis and Immune System as Potential Therapeutic Targets

Genes and Cancer
Cancer ResearchGenetics
2015English

Determining Therapeutic Susceptibility in Multiple Myeloma by Single-Cell Mass Accumulation

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2017English

Induction Therapy and Stem Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma

Stem Cells International
Cell BiologyMolecular Biology
2012English

Evolving Therapeutic Role of Bisphosphonates in Multiple Myeloma

British Journal of Cancer
Cancer ResearchOncology
2005English

Management of Older Patients With Multiple Myeloma

Blood Reviews
OncologyHematology
2011English

Reply to "Response to "CD20 Positive Cells Are Undetectable in the Majority of Multiple Myeloma Cell Lines and Are Not Associated With a Cancer Stem Cell Phenotype". Haematologica 2012;97(7):1110-1114

Haematologica
Hematology
2012English

Acute Cognitive Impairment in Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplant

Cancer
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy